Free Trial

Invesco Ltd. Has $44.18 Million Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Sabra Healthcare REIT logo with Finance background

Key Points

  • Invesco Ltd. has reduced its stake in Sabra Healthcare REIT by 1.1%, holding approximately $44.18 million worth of shares after selling 27,374 shares during the first quarter.
  • A number of institutional investors have increased their positions in Sabra Healthcare, with UMB Bank raising its stake by 379.6% in the same period.
  • Sabra Healthcare REIT declared a quarterly dividend of $0.30 per share, resulting in an annualized dividend yield of 6.5%.
  • Five stocks to consider instead of Sabra Healthcare REIT.

Invesco Ltd. cut its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 1.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,528,844 shares of the real estate investment trust's stock after selling 27,374 shares during the period. Invesco Ltd. owned about 1.06% of Sabra Healthcare REIT worth $44,179,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. State of Michigan Retirement System boosted its stake in Sabra Healthcare REIT by 1.1% in the 1st quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust's stock valued at $990,000 after buying an additional 600 shares in the last quarter. Louisiana State Employees Retirement System boosted its stake in Sabra Healthcare REIT by 0.9% in the 1st quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust's stock valued at $1,158,000 after buying an additional 600 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in Sabra Healthcare REIT by 17.2% in the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after buying an additional 642 shares in the last quarter. Diversify Advisory Services LLC boosted its stake in Sabra Healthcare REIT by 5.7% in the 1st quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust's stock valued at $226,000 after buying an additional 689 shares in the last quarter. Finally, IFP Advisors Inc boosted its stake in Sabra Healthcare REIT by 16.2% in the 1st quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock valued at $88,000 after buying an additional 706 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock traded up $0.2250 on Friday, reaching $19.8450. The company's stock had a trading volume of 705,595 shares, compared to its average volume of 2,445,709. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The company has a market cap of $4.76 billion, a price-to-earnings ratio of 26.11, a PEG ratio of 1.55 and a beta of 0.86. The business's fifty day moving average price is $18.42 and its 200 day moving average price is $17.67. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business's revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.0%. Sabra Healthcare REIT's payout ratio is currently 157.89%.

Analysts Set New Price Targets

Several brokerages recently commented on SBRA. Scotiabank boosted their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. JMP Securities boosted their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $20.00.

Check Out Our Latest Report on Sabra Healthcare REIT

Sabra Healthcare REIT Profile

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

See Also

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.